| |
| |
|
| Insider
Information: |
Matsui Connie |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
273,009 |
|
|
Indirect Shares
|
40,766 |
|
|
| Direct
Value |
$13,186,061 |
|
|
|
Indirect Value
|
$8,740,638 |
|
|
| Total
Shares |
313,775 |
|
|
| Total
Value |
$21,926,699 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
2.0
|
| Percentage
Gain/Loss : |
 -16.5%
|
 66.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
EVP, Corp. Strategy an... |
2007-02-12 |
22,837 |
2007-02-12 |
40,766 |
Premium* |
|
|
Halozyme Therapeutics Inc |
HALO |
|
2024-04-25 |
193,505 |
|
0 |
Premium* |
|
|
Artelo Biosciences, Inc. |
ARTL |
|
2020-05-04 |
56,667 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2019-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
12,173 |
239,924 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2020-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,829 |
248,753 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2020-09-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,000 |
208,753 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2021-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
5,230 |
213,983 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
|
– • – |
2022-11-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,250 |
178,939 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
|
– • – |
2023-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
8,065 |
187,004 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
|
– • – |
2024-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
6,501 |
193,505 |
0 |
- |
|
| ARTL |
Artelo Biosciences, Inc. |
|
– • – |
2020-05-04 |
4 |
B |
$1.20 |
$50,000 |
D/D |
41,667 |
56,667 |
0.01 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2015-09-14 |
4 |
OE |
$2.33 |
$72,700 |
D/D |
20,000 |
203,051 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Sr V P, Planning& Resource Dev |
• – – |
2003-11-19 |
4 |
OE |
$3.50 |
$216,766 |
D/D |
40,000 |
187,371 |
|
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2008-05-08 |
4 |
A |
$4.94 |
$74,100 |
D/D |
15,000 |
45,000 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2004-05-18 |
4/A |
OE |
$6.92 |
$415,002 |
D/D |
60,000 |
230,274 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2004-05-18 |
4 |
OE |
$6.92 |
$415,002 |
D/D |
60,000 |
107,998 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2004-08-20 |
4 |
OE |
$6.92 |
$553,336 |
D/D |
80,000 |
87,998 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2007-01-16 |
4 |
OE |
$6.92 |
$185,189 |
D/D |
24,823 |
47,394 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Sr V P, Planning& Resource Dev |
• – – |
2003-11-25 |
4 |
OE |
$7.72 |
$30,397 |
D/D |
3,938 |
169,335 |
|
- |
|
| BIIB |
Biogen Idec Inc |
officerTitle |
• – – |
2005-10-12 |
4 |
OE |
$7.72 |
$299,266 |
D/D |
38,771 |
175,596 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2005-10-12 |
4/A |
OE |
$7.72 |
$299,266 |
D/D |
38,771 |
50,438 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2006-04-28 |
4 |
OE |
$7.72 |
$308,752 |
D/D |
40,000 |
136,825 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2006-07-17 |
4 |
OE |
$7.72 |
$308,752 |
D/D |
40,000 |
52,344 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Corp. Strategy and Comm. |
• – – |
2006-10-16 |
4 |
OE |
$7.72 |
$308,752 |
D/D |
40,000 |
62,571 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2007-05-15 |
4 |
A |
$10.37 |
$155,550 |
D/D |
15,000 |
30,000 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2017-05-08 |
4 |
OE |
$10.37 |
$103,700 |
D/D |
10,000 |
247,388 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
Director |
– • – |
2020-09-11 |
4 |
S |
$27.06 |
$865,792 |
D/D |
(32,000) |
216,753 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
officerTitle |
• – – |
2003-03-31 |
4 |
A |
$29.09 |
$10,675 |
D/D |
367 |
172,397 |
|
- |
|
65 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
